Lifeward (LFWD) EBT Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 7,438.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,438.00 |
| Dec 31, 2025 | 11,983.00 |
| Sep 30, 2025 | 56,226.00 |
| Jun 30, 2025 | 16,689.00 |
| Mar 31, 2025 | 39,643.00 |
| Dec 31, 2024 | 10,383.00 |
| Sep 30, 2024 | 8,651.00 |
| Jun 30, 2024 | 15,401.00 |
| Mar 31, 2024 | 11,057.00 |
| Dec 31, 2023 | 16,153.00 |
| Sep 30, 2023 | 27,220.00 |
| Jun 30, 2023 | -17,697.00 |
| Mar 31, 2023 | 15,697.00 |
| Dec 31, 2022 | 7,593.00 |
| Sep 30, 2022 | -33,852.00 |
| Jun 30, 2022 | 24,162.00 |
| Mar 31, 2022 | -23,968.00 |
| Dec 31, 2021 | 1,209.00 |
| Sep 30, 2021 | 14,367.00 |
| Jun 30, 2021 | 10,946.00 |
| Mar 31, 2021 | 17,144.00 |
| Dec 31, 2020 | 15,595.00 |
| Sep 30, 2020 | -10,658.00 |
| Jun 30, 2020 | 14,746.00 |
| Mar 31, 2020 | -25,077.00 |
| Dec 31, 2019 | 23,683.00 |
| Sep 30, 2019 | 29,027.00 |
| Jun 30, 2019 | 59,130.00 |
| Mar 31, 2019 | 8,242.00 |
| Dec 31, 2018 | 24,368.00 |
| Sep 30, 2018 | 26,676.00 |
| Jun 30, 2018 | 62,210.00 |
| Mar 31, 2018 | 49,537.00 |
| Dec 31, 2017 | -2,652.00 |
| Sep 30, 2017 | 8,093.00 |
| Dec 31, 2016 | 35,993.00 |
| Sep 30, 2016 | 23,664.00 |